SlideShare a Scribd company logo
Dysproteinemias Related Renal Disorders
Monoclonal Gammopathy (Paraproteinemia)
Nephrology Perspective
Mohammed Abdel Gawad
Lecturer of Nephrology, School of Medicine, NewGiza University
Nephrology Consultant, Alexandria
MD Nephrology, Mansoura University
European Specialty Examination in Nephrology (ESENeph) – UK
Founder of NephroTube.com
Annual Conference of Assiut – Nephrology Chapter – 28 October 2021
To download the lecture
contact me
drgawad@gmail.com
For more Nephrology lectures visit
www.NephroTube.com
Talk Outline
• Back to basics
• Kidney deposits: Hypothesized mechanism / Clinical presentation
• Dysproteinemia diagnosis: Lab
• Dysproteinemia diagnosis: Renal biopsy
• Dysproteinemia diagnosis: Bone marrow biopsy
• Monoclonal Gammopathy of Renal Significance (MGRS)
• High cutoff dialyzers
• Final message
Talk Outline
• Back to basics
• Kidney deposits: Hypothesized mechanism / Clinical presentation
• Dysproteinemia diagnosis: Lab
• Dysproteinemia diagnosis: Renal biopsy
• Dysproteinemia diagnosis: Bone marrow biopsy
• Monoclonal Gammopathy of Renal Significance (MGRS)
• High cutoff dialyzers
• Final message
Monoclonal Abs (Ig, Gama Globulin)
• Antibodies that are identical
because they were produced by
one type of B cell.
• Detect only one epitope on the
antigen.
• Antibodies that are non-identical
because they were produced by
different B cell resources.
• Detect multiple epitopes on any
one antigen.
Polyclonal Abs (Ig, Gama Globulin)
Semin Immunol. 2008;20:49
Monoclonal gammopathy (paraproteinemia) signifies the
production of monoclonal immunoglobulin or
immunoglobulin fragments (i.e., light or heavy chains) by a
clonal proliferation of plasma cells or B cells
Am J Kidney Dis (2019), 74(6):822-836
Talk Outline
• Back to basics
• Kidney deposits: Hypothesized mechanism / Clinical presentation
• Dysproteinemia diagnosis: Lab
• Dysproteinemia diagnosis: Renal biopsy
• Dysproteinemia diagnosis: Bone marrow biopsy
• Monoclonal Gammopathy of Renal Significance (MGRS)
• High cutoff dialyzers
• Final message
Monoclonal gammopathy -
associated renal lesions
Kidney International (2015) 87, 698–711
Kidney International (2015) 87, 698–711
Dysproteinemia-Associated Kidney Diseases:
Hypothesized mechanism of injury
Am J Kidney Dis (2019), 74(6):822-836
Dysproteinemia-Associated Kidney Diseases:
Hypothesized mechanism of injury
Am J Kidney Dis (2019), 74(6):822-836
Talk Outline
• Back to basics
• Kidney deposits: Hypothesized mechanism / Clinical presentation
• Dysproteinemia diagnosis: Lab
• Dysproteinemia diagnosis: Renal biopsy
• Dysproteinemia diagnosis: Bone marrow biopsy
• Monoclonal Gammopathy of Renal Significance (MGRS)
• High cutoff dialyzers
• Final message
Serum protein electrophoresis (SPE)
Paraprotein is
a monoclonal Ig (gamma globulin)
that is produced in excess
by the clonal proliferation of plasma cells
Electrophoresis. 1997;18:1775-1780
Serum protein
electrophoresis (SPE)
Serum immunofixation
electrophoresis (sIFE)
Can detect the whole immunoglobulin
(cannot reliably differentiate monoclonal from polyclonal light
chain expansion)
10 times more sensitive for immunoglobulins
Only detects increased LC in patients
who have very high levels of LC-only myeloma
10 times more sensitive for LC
Semi-quantitative Not quantitative
Laboratory Diagnostic Tests
Clin Chem. 2002;48(9):1437-1444
Urine PEP, immunofixation
electrophoresis (uIFS)
(to detect Bence Jones Proteinuria)
Serum PEP, immunofixation
electrophoresis (sIFE)
• Can detect low levels of LC
• Yet remains less sensitive than sFLC measurement because
sFLC are elevated before urine overflow may occur.
More sensitive
Dr. Henry Bence-Jones
31 December 1813 / / April 20, 1873
Laboratory Diagnostic Tests
Serum Free Light Chains (к and λ) Measurement
Normal к/λ CKD к/λ Abnormal к/λ ratio
0.26–1.65
0.37–3.17
Significant accumulation of sFLC occurs
(approximately five-fold)
Occurs as a result of
overproduction of a
single к or λ clone
Am J Kidney Dis (2019), 74(6):822-836
Am J Kidney Dis (2019), 74(6):822-836
Dysproteinemia-Associated Kidney Diseases:
Paraprotein detection rate
Am J Kidney Dis (2019), 74(6):822-836
Diagnosis of dysproteinemia
Urine Analysis
Discrepancy between PCR in
urine and dipstick results
suggests LC deposition disease
Light chain proteins are not
detected by dipstick but are
counted through PCR
Light chain proteins are
counted through PCR but
will not affect ACR
Discrepancy between PCR and
ACR in urine
suggests LC deposition disease
Talk Outline
• Back to basics
• Kidney deposits: Hypothesized mechanism / Clinical presentation
• Dysproteinemia diagnosis: Lab
• Dysproteinemia diagnosis: Renal biopsy
• Dysproteinemia diagnosis: Bone marrow biopsy
• Monoclonal Gammopathy of Renal Significance (MGRS)
• High cutoff dialyzers
• Final message
Comprehensive Clinical Nephrology. 4th edition, chapter 26
J Am Soc Nephrol 19: 34–37, 2008
J Am Soc Nephrol 19: 34–37, 2008
J Am Soc Nephrol 19: 34–37, 2008
DNAJB9 is novel proteomic tissue biomarker specific for fibrillary
glomerulonephritis on immunohistochemistry
Kidney Int Rep. 2017 Aug 8;3(1):56-64
Immunotactoid glomerulopathy
Am J Kidney Dis (2019), 74(6):822-836
κ light chain monoclonal immunoglobulin deposition disease
Am J Kidney Dis (2019), 74(6):822-836
Proliferative glomerulonephritis with monoclonal
immunoglobulin G3 (IgG3) κ deposits
Am J Kidney Dis (2019), 74(6):822-836
Am J Kidney Dis (2019), 74(6):822-836
Light chain cast nephropathy
Talk Outline
• Back to basics
• Kidney deposits: Hypothesized mechanism / Clinical presentation
• Dysproteinemia diagnosis: Lab
• Dysproteinemia diagnosis: Renal biopsy
• Dysproteinemia diagnosis: Bone marrow biopsy
• Monoclonal Gammopathy of Renal Significance (MGRS)
• High cutoff dialyzers
• Final message
Kidney International (2011) 79, 1289–1301
Dysproteinemia-Associated Kidney Diseases:
Clone detection
Am J Kidney Dis (2019), 74(6):822-836
Dysproteinemia-Associated Kidney Diseases:
Clone detection
Talk Outline
• Back to basics
• Kidney deposits: Hypothesized mechanism / Clinical presentation
• Dysproteinemia diagnosis: Lab
• Dysproteinemia diagnosis: Renal biopsy
• Dysproteinemia diagnosis: Bone marrow biopsy
• Monoclonal Gammopathy of Renal Significance (MGRS)
• High cutoff dialyzers
• Final message
MGUS MGRS
Smoldering
(asymptomatic)
myeloma
Active (symptomatic) myeloma
Serum M-protein <3 g/100ml <3 g/100ml 3 g/100ml 3 g/100ml
Bone marrow
clonal plasma
cells
<10% <10% 10%
10%
or Plasmacytoma
Related organ or
tissue
impairment
Absent
and
No evidence of
other B-cell
proliferative
disorders
Renal injury
Absent/
Asymptomatic
Requires 1 or more of the following:
• Calcium elevation
• Renal insufficiency
• Anaemia
• Bone osteolytic lesion
Monoclonal Gammopathy of Renal Significance (MGRS)
Am J Kidney Dis (2019), 74(6):822-836
Talk Outline
• Back to basics
• Kidney deposits: Hypothesized mechanism / Clinical presentation
• Dysproteinemia diagnosis: Lab
• Dysproteinemia diagnosis: Renal biopsy
• Dysproteinemia diagnosis: Bone marrow biopsy
• Monoclonal Gammopathy of Renal Significance (MGRS)
• High cutoff dialyzers
• Final message
JAMA. 2017;318(21):2099-2110
94 patients
MYRE Trial
JAMA. 2017;318(21):2099-2110
90 patients
Lancet Haematol. 2019 Apr;6(4):e217-e228
Talk Outline
• Back to basics
• Kidney deposits: Hypothesized mechanism / Clinical presentation
• Dysproteinemia diagnosis: Lab
• Dysproteinemia diagnosis: Renal biopsy
• Dysproteinemia diagnosis: Bone marrow biopsy
• Monoclonal Gammopathy of Renal Significance (MGRS)
• High cutoff dialyzers
• Final message
Suspected dysproteinemia in a kidney disease
SPEP, Serum immunofixation,
SFLC
+ve for dysproteinemia
Bone marrow biopsy
Target treatment for the
type of clonal
proliferation
-ve for dysproteinemia
High suspicion for dysproteinemia in a
kidney disease
Renal biopsy
+ve for
dysproteinemia
-ve for
dysproteinemia
Follow up and treatment
according to presentation
Thank You
drgawad@gmail.com
www.NephroTube.com

More Related Content

What's hot

Ckd mbd
Ckd mbdCkd mbd
Ckd mbd
Harsh shaH
 
Electrolytes & Acid-Base Disturbance Workshop - Dr. Gawad
Electrolytes & Acid-Base Disturbance Workshop - Dr. GawadElectrolytes & Acid-Base Disturbance Workshop - Dr. Gawad
Electrolytes & Acid-Base Disturbance Workshop - Dr. Gawad
NephroTube - Dr.Gawad
 
Ig A nephropathy
Ig A nephropathyIg A nephropathy
Ig A nephropathy
Dr Shami Bhagat
 
Challenges in Diagnosis and Management of Diabetic Kidney Disease - Dr. Gawad
Challenges in Diagnosis and Management of Diabetic Kidney Disease - Dr. GawadChallenges in Diagnosis and Management of Diabetic Kidney Disease - Dr. Gawad
Challenges in Diagnosis and Management of Diabetic Kidney Disease - Dr. Gawad
NephroTube - Dr.Gawad
 
IntraDialytic Hypertension (Basic Science → Evidence → Practice) - Dr. Gawad
IntraDialytic Hypertension (Basic Science → Evidence → Practice) - Dr. GawadIntraDialytic Hypertension (Basic Science → Evidence → Practice) - Dr. Gawad
IntraDialytic Hypertension (Basic Science → Evidence → Practice) - Dr. Gawad
NephroTube - Dr.Gawad
 
CKD MBD chronic kidney disease mineral bone disease Dr. Abdel Rahman Mansy
CKD MBD chronic kidney disease mineral bone disease Dr. Abdel Rahman MansyCKD MBD chronic kidney disease mineral bone disease Dr. Abdel Rahman Mansy
CKD MBD chronic kidney disease mineral bone disease Dr. Abdel Rahman Mansy
Internal medicine department, faculty of Medicine Beni-Suef University Egypt
 
HTN in Hemodialysis Patients - A Clinical Approach of Management - Dr. Gawad
HTN in Hemodialysis Patients - A Clinical Approach of Management - Dr. GawadHTN in Hemodialysis Patients - A Clinical Approach of Management - Dr. Gawad
HTN in Hemodialysis Patients - A Clinical Approach of Management - Dr. Gawad
NephroTube - Dr.Gawad
 
CKD Mineral Bone Disorder (CKD-MBD) - Dr. Gawad
CKD Mineral Bone Disorder (CKD-MBD) - Dr. GawadCKD Mineral Bone Disorder (CKD-MBD) - Dr. Gawad
CKD Mineral Bone Disorder (CKD-MBD) - Dr. Gawad
NephroTube - Dr.Gawad
 
Is it Hepatorenal Syndrome? - Dr. Gawad
Is it Hepatorenal Syndrome? - Dr. GawadIs it Hepatorenal Syndrome? - Dr. Gawad
Is it Hepatorenal Syndrome? - Dr. Gawad
NephroTube - Dr.Gawad
 
Hyperuricemia in CKD
Hyperuricemia in CKDHyperuricemia in CKD
Hyperuricemia in CKD
Sidney Erwin Manahan
 
Hypocalcemia (Practical Approach) - Dr. Gawad
Hypocalcemia (Practical Approach) - Dr. GawadHypocalcemia (Practical Approach) - Dr. Gawad
Hypocalcemia (Practical Approach) - Dr. Gawad
NephroTube - Dr.Gawad
 
Focal Segmental Glomerulosclerosis - FSGS (KDIGO 2021 Guidelines) - Dr. Gawad
Focal Segmental Glomerulosclerosis - FSGS (KDIGO 2021 Guidelines) - Dr. GawadFocal Segmental Glomerulosclerosis - FSGS (KDIGO 2021 Guidelines) - Dr. Gawad
Focal Segmental Glomerulosclerosis - FSGS (KDIGO 2021 Guidelines) - Dr. Gawad
NephroTube - Dr.Gawad
 
Anemia in Chronic Kidney DIsease
Anemia in Chronic Kidney DIseaseAnemia in Chronic Kidney DIsease
Anemia in Chronic Kidney DIseaseVishal Golay
 
Urine Analysis (Practical Approach) - Dr. Gawad
Urine Analysis (Practical Approach) - Dr. GawadUrine Analysis (Practical Approach) - Dr. Gawad
Urine Analysis (Practical Approach) - Dr. Gawad
NephroTube - Dr.Gawad
 
Delayed Graft Function post kidney transplant, Moh'd sharshir
Delayed Graft Function post kidney transplant, Moh'd sharshirDelayed Graft Function post kidney transplant, Moh'd sharshir
Delayed Graft Function post kidney transplant, Moh'd sharshir
Moh'd sharshir
 
CKD MBD - Think Outside The Box - Case Scenarios Snapshots - Dr. Gawad
CKD MBD - Think Outside The Box - Case Scenarios Snapshots  - Dr. GawadCKD MBD - Think Outside The Box - Case Scenarios Snapshots  - Dr. Gawad
CKD MBD - Think Outside The Box - Case Scenarios Snapshots - Dr. Gawad
NephroTube - Dr.Gawad
 
Hypercalcemia (Practical Approach) - Dr. Gawad
Hypercalcemia (Practical Approach) - Dr. GawadHypercalcemia (Practical Approach) - Dr. Gawad
Hypercalcemia (Practical Approach) - Dr. Gawad
NephroTube - Dr.Gawad
 
Uric acid and CKD (Consequences, Management and Evidence) - Dr. Gawad
Uric acid and CKD (Consequences, Management and Evidence) - Dr. GawadUric acid and CKD (Consequences, Management and Evidence) - Dr. Gawad
Uric acid and CKD (Consequences, Management and Evidence) - Dr. Gawad
NephroTube - Dr.Gawad
 
CKD Progression (Pharmacological Approach) - Dr. Gawad
CKD Progression (Pharmacological Approach) - Dr. GawadCKD Progression (Pharmacological Approach) - Dr. Gawad
CKD Progression (Pharmacological Approach) - Dr. Gawad
NephroTube - Dr.Gawad
 
CKD MBD; make it easy
CKD MBD; make it easyCKD MBD; make it easy
CKD MBD; make it easy
Shady Yousef
 

What's hot (20)

Ckd mbd
Ckd mbdCkd mbd
Ckd mbd
 
Electrolytes & Acid-Base Disturbance Workshop - Dr. Gawad
Electrolytes & Acid-Base Disturbance Workshop - Dr. GawadElectrolytes & Acid-Base Disturbance Workshop - Dr. Gawad
Electrolytes & Acid-Base Disturbance Workshop - Dr. Gawad
 
Ig A nephropathy
Ig A nephropathyIg A nephropathy
Ig A nephropathy
 
Challenges in Diagnosis and Management of Diabetic Kidney Disease - Dr. Gawad
Challenges in Diagnosis and Management of Diabetic Kidney Disease - Dr. GawadChallenges in Diagnosis and Management of Diabetic Kidney Disease - Dr. Gawad
Challenges in Diagnosis and Management of Diabetic Kidney Disease - Dr. Gawad
 
IntraDialytic Hypertension (Basic Science → Evidence → Practice) - Dr. Gawad
IntraDialytic Hypertension (Basic Science → Evidence → Practice) - Dr. GawadIntraDialytic Hypertension (Basic Science → Evidence → Practice) - Dr. Gawad
IntraDialytic Hypertension (Basic Science → Evidence → Practice) - Dr. Gawad
 
CKD MBD chronic kidney disease mineral bone disease Dr. Abdel Rahman Mansy
CKD MBD chronic kidney disease mineral bone disease Dr. Abdel Rahman MansyCKD MBD chronic kidney disease mineral bone disease Dr. Abdel Rahman Mansy
CKD MBD chronic kidney disease mineral bone disease Dr. Abdel Rahman Mansy
 
HTN in Hemodialysis Patients - A Clinical Approach of Management - Dr. Gawad
HTN in Hemodialysis Patients - A Clinical Approach of Management - Dr. GawadHTN in Hemodialysis Patients - A Clinical Approach of Management - Dr. Gawad
HTN in Hemodialysis Patients - A Clinical Approach of Management - Dr. Gawad
 
CKD Mineral Bone Disorder (CKD-MBD) - Dr. Gawad
CKD Mineral Bone Disorder (CKD-MBD) - Dr. GawadCKD Mineral Bone Disorder (CKD-MBD) - Dr. Gawad
CKD Mineral Bone Disorder (CKD-MBD) - Dr. Gawad
 
Is it Hepatorenal Syndrome? - Dr. Gawad
Is it Hepatorenal Syndrome? - Dr. GawadIs it Hepatorenal Syndrome? - Dr. Gawad
Is it Hepatorenal Syndrome? - Dr. Gawad
 
Hyperuricemia in CKD
Hyperuricemia in CKDHyperuricemia in CKD
Hyperuricemia in CKD
 
Hypocalcemia (Practical Approach) - Dr. Gawad
Hypocalcemia (Practical Approach) - Dr. GawadHypocalcemia (Practical Approach) - Dr. Gawad
Hypocalcemia (Practical Approach) - Dr. Gawad
 
Focal Segmental Glomerulosclerosis - FSGS (KDIGO 2021 Guidelines) - Dr. Gawad
Focal Segmental Glomerulosclerosis - FSGS (KDIGO 2021 Guidelines) - Dr. GawadFocal Segmental Glomerulosclerosis - FSGS (KDIGO 2021 Guidelines) - Dr. Gawad
Focal Segmental Glomerulosclerosis - FSGS (KDIGO 2021 Guidelines) - Dr. Gawad
 
Anemia in Chronic Kidney DIsease
Anemia in Chronic Kidney DIseaseAnemia in Chronic Kidney DIsease
Anemia in Chronic Kidney DIsease
 
Urine Analysis (Practical Approach) - Dr. Gawad
Urine Analysis (Practical Approach) - Dr. GawadUrine Analysis (Practical Approach) - Dr. Gawad
Urine Analysis (Practical Approach) - Dr. Gawad
 
Delayed Graft Function post kidney transplant, Moh'd sharshir
Delayed Graft Function post kidney transplant, Moh'd sharshirDelayed Graft Function post kidney transplant, Moh'd sharshir
Delayed Graft Function post kidney transplant, Moh'd sharshir
 
CKD MBD - Think Outside The Box - Case Scenarios Snapshots - Dr. Gawad
CKD MBD - Think Outside The Box - Case Scenarios Snapshots  - Dr. GawadCKD MBD - Think Outside The Box - Case Scenarios Snapshots  - Dr. Gawad
CKD MBD - Think Outside The Box - Case Scenarios Snapshots - Dr. Gawad
 
Hypercalcemia (Practical Approach) - Dr. Gawad
Hypercalcemia (Practical Approach) - Dr. GawadHypercalcemia (Practical Approach) - Dr. Gawad
Hypercalcemia (Practical Approach) - Dr. Gawad
 
Uric acid and CKD (Consequences, Management and Evidence) - Dr. Gawad
Uric acid and CKD (Consequences, Management and Evidence) - Dr. GawadUric acid and CKD (Consequences, Management and Evidence) - Dr. Gawad
Uric acid and CKD (Consequences, Management and Evidence) - Dr. Gawad
 
CKD Progression (Pharmacological Approach) - Dr. Gawad
CKD Progression (Pharmacological Approach) - Dr. GawadCKD Progression (Pharmacological Approach) - Dr. Gawad
CKD Progression (Pharmacological Approach) - Dr. Gawad
 
CKD MBD; make it easy
CKD MBD; make it easyCKD MBD; make it easy
CKD MBD; make it easy
 

Similar to Dysproteinemias Related Renal Disorders, Monoclonal Gammopathy (Paraproteinemia), Nephrology Perspective - Dr. Gawad

Ci aki for nst 2015
Ci aki for nst 2015Ci aki for nst 2015
Ci aki for nst 2015
Mahidol University
 
The aging kidney and what we should (not?) do about it
The aging kidney and what we should (not?) do about itThe aging kidney and what we should (not?) do about it
The aging kidney and what we should (not?) do about it
Christos Argyropoulos
 
The aging kidney and what we should (not?) do about it
The aging kidney and what we should (not?) do about itThe aging kidney and what we should (not?) do about it
The aging kidney and what we should (not?) do about it
Christos Argyropoulos
 
Nephrorounds3 2015final-150907110921-lva1-app6892
Nephrorounds3 2015final-150907110921-lva1-app6892Nephrorounds3 2015final-150907110921-lva1-app6892
Nephrorounds3 2015final-150907110921-lva1-app6892
Gordhan Das asani
 
Core series: Acute Kidney Injury part 1
Core series: Acute Kidney Injury part 1 Core series: Acute Kidney Injury part 1
Core series: Acute Kidney Injury part 1
Adeel Rafi Ahmed
 
renal biopsy
renal biopsyrenal biopsy
renal biopsy
FarragBahbah
 
Drug induced nephritis
Drug induced nephritis Drug induced nephritis
Drug induced nephritis
Joseph Openy
 
Physician's Meeting 23/4/2013 - Challenging Nephrotic Syndrome
Physician's Meeting 23/4/2013 - Challenging Nephrotic SyndromePhysician's Meeting 23/4/2013 - Challenging Nephrotic Syndrome
Physician's Meeting 23/4/2013 - Challenging Nephrotic Syndrome
Richard McCrory
 
Uremia
UremiaUremia
Uremia
MNDU net
 
[Int. med] anemia from SIMS Lahore
[Int. med] anemia from SIMS Lahore[Int. med] anemia from SIMS Lahore
[Int. med] anemia from SIMS Lahore
Muhammad Ahmad
 
23 renal disease
23 renal disease23 renal disease
23 renal diseaseinternalmed
 
Polycystic Kidney Disease
Polycystic Kidney DiseasePolycystic Kidney Disease
Polycystic Kidney Disease
Divya Narayanan
 
Renal Failure Presented By Uzma Nawab.pptx
Renal Failure Presented By Uzma Nawab.pptxRenal Failure Presented By Uzma Nawab.pptx
Renal Failure Presented By Uzma Nawab.pptx
yasirshahabuddin78
 
Chronic Kidney Disease in Primary Care
Chronic Kidney Disease in Primary CareChronic Kidney Disease in Primary Care
Chronic Kidney Disease in Primary Care
Christos Argyropoulos
 
Cystic kidney diseases m. mustafa
Cystic kidney diseases m. mustafaCystic kidney diseases m. mustafa
Cystic kidney diseases m. mustafa
Mohamed E. Elrggal
 
Developmental Renal Pseudotumours
Developmental Renal PseudotumoursDevelopmental Renal Pseudotumours
Developmental Renal Pseudotumours
Muhibullah Bangash
 
uremia, treatment, symptoms , 12222.pptx
uremia, treatment, symptoms , 12222.pptxuremia, treatment, symptoms , 12222.pptx
uremia, treatment, symptoms , 12222.pptx
ddjumanalieva97
 
Multiple Myeloma
Multiple MyelomaMultiple Myeloma
Multiple Myeloma
OscarKwan6
 
Approach to a case of Obstructive jaundice
Approach to a case of Obstructive jaundiceApproach to a case of Obstructive jaundice
Approach to a case of Obstructive jaundice
Supreet Kumar
 
What Rheumatologists Learn from Nephrologists
What Rheumatologists Learn from Nephrologists What Rheumatologists Learn from Nephrologists
What Rheumatologists Learn from Nephrologists
Samar Tharwat
 

Similar to Dysproteinemias Related Renal Disorders, Monoclonal Gammopathy (Paraproteinemia), Nephrology Perspective - Dr. Gawad (20)

Ci aki for nst 2015
Ci aki for nst 2015Ci aki for nst 2015
Ci aki for nst 2015
 
The aging kidney and what we should (not?) do about it
The aging kidney and what we should (not?) do about itThe aging kidney and what we should (not?) do about it
The aging kidney and what we should (not?) do about it
 
The aging kidney and what we should (not?) do about it
The aging kidney and what we should (not?) do about itThe aging kidney and what we should (not?) do about it
The aging kidney and what we should (not?) do about it
 
Nephrorounds3 2015final-150907110921-lva1-app6892
Nephrorounds3 2015final-150907110921-lva1-app6892Nephrorounds3 2015final-150907110921-lva1-app6892
Nephrorounds3 2015final-150907110921-lva1-app6892
 
Core series: Acute Kidney Injury part 1
Core series: Acute Kidney Injury part 1 Core series: Acute Kidney Injury part 1
Core series: Acute Kidney Injury part 1
 
renal biopsy
renal biopsyrenal biopsy
renal biopsy
 
Drug induced nephritis
Drug induced nephritis Drug induced nephritis
Drug induced nephritis
 
Physician's Meeting 23/4/2013 - Challenging Nephrotic Syndrome
Physician's Meeting 23/4/2013 - Challenging Nephrotic SyndromePhysician's Meeting 23/4/2013 - Challenging Nephrotic Syndrome
Physician's Meeting 23/4/2013 - Challenging Nephrotic Syndrome
 
Uremia
UremiaUremia
Uremia
 
[Int. med] anemia from SIMS Lahore
[Int. med] anemia from SIMS Lahore[Int. med] anemia from SIMS Lahore
[Int. med] anemia from SIMS Lahore
 
23 renal disease
23 renal disease23 renal disease
23 renal disease
 
Polycystic Kidney Disease
Polycystic Kidney DiseasePolycystic Kidney Disease
Polycystic Kidney Disease
 
Renal Failure Presented By Uzma Nawab.pptx
Renal Failure Presented By Uzma Nawab.pptxRenal Failure Presented By Uzma Nawab.pptx
Renal Failure Presented By Uzma Nawab.pptx
 
Chronic Kidney Disease in Primary Care
Chronic Kidney Disease in Primary CareChronic Kidney Disease in Primary Care
Chronic Kidney Disease in Primary Care
 
Cystic kidney diseases m. mustafa
Cystic kidney diseases m. mustafaCystic kidney diseases m. mustafa
Cystic kidney diseases m. mustafa
 
Developmental Renal Pseudotumours
Developmental Renal PseudotumoursDevelopmental Renal Pseudotumours
Developmental Renal Pseudotumours
 
uremia, treatment, symptoms , 12222.pptx
uremia, treatment, symptoms , 12222.pptxuremia, treatment, symptoms , 12222.pptx
uremia, treatment, symptoms , 12222.pptx
 
Multiple Myeloma
Multiple MyelomaMultiple Myeloma
Multiple Myeloma
 
Approach to a case of Obstructive jaundice
Approach to a case of Obstructive jaundiceApproach to a case of Obstructive jaundice
Approach to a case of Obstructive jaundice
 
What Rheumatologists Learn from Nephrologists
What Rheumatologists Learn from Nephrologists What Rheumatologists Learn from Nephrologists
What Rheumatologists Learn from Nephrologists
 

More from NephroTube - Dr.Gawad

Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.GawadHemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.GawadHemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
NephroTube - Dr.Gawad
 
Vitamin D in Chronic Kidney Disease Which type, Which dose, Which patient? - ...
Vitamin D in Chronic Kidney Disease Which type, Which dose, Which patient? - ...Vitamin D in Chronic Kidney Disease Which type, Which dose, Which patient? - ...
Vitamin D in Chronic Kidney Disease Which type, Which dose, Which patient? - ...
NephroTube - Dr.Gawad
 
Urinary Tract Infection (Clinical Tips) - Dr. Gawad
Urinary Tract Infection (Clinical Tips) - Dr. GawadUrinary Tract Infection (Clinical Tips) - Dr. Gawad
Urinary Tract Infection (Clinical Tips) - Dr. Gawad
NephroTube - Dr.Gawad
 
Contrast and the kidney - Dr. Gawad
Contrast and the kidney - Dr. GawadContrast and the kidney - Dr. Gawad
Contrast and the kidney - Dr. Gawad
NephroTube - Dr.Gawad
 
Obesity and the Kidney (Link and Evidence) - Dr. Gawad
Obesity and the Kidney (Link and Evidence) - Dr. GawadObesity and the Kidney (Link and Evidence) - Dr. Gawad
Obesity and the Kidney (Link and Evidence) - Dr. Gawad
NephroTube - Dr.Gawad
 
Thrombotic Microangiopathy (TMA) in Adults and Acute Kidney Injury - Dr. Gawad
Thrombotic Microangiopathy (TMA) in Adults and Acute Kidney Injury - Dr. GawadThrombotic Microangiopathy (TMA) in Adults and Acute Kidney Injury - Dr. Gawad
Thrombotic Microangiopathy (TMA) in Adults and Acute Kidney Injury - Dr. Gawad
NephroTube - Dr.Gawad
 
Asymptomatic Hyperuricemia with CKD (To Treat or Not To Treat) - Dr. Gawad
Asymptomatic Hyperuricemia with CKD (To Treat or Not To Treat) - Dr. GawadAsymptomatic Hyperuricemia with CKD (To Treat or Not To Treat) - Dr. Gawad
Asymptomatic Hyperuricemia with CKD (To Treat or Not To Treat) - Dr. Gawad
NephroTube - Dr.Gawad
 
ANCA vasculitis (KDIGO 2021 Guidelines) - Dr. Gawad
ANCA vasculitis (KDIGO 2021 Guidelines) - Dr. GawadANCA vasculitis (KDIGO 2021 Guidelines) - Dr. Gawad
ANCA vasculitis (KDIGO 2021 Guidelines) - Dr. Gawad
NephroTube - Dr.Gawad
 
Lupus Nephritis (KDIGO 2021 Guidelines) - Dr. Gawad
Lupus Nephritis (KDIGO 2021 Guidelines) - Dr. GawadLupus Nephritis (KDIGO 2021 Guidelines) - Dr. Gawad
Lupus Nephritis (KDIGO 2021 Guidelines) - Dr. Gawad
NephroTube - Dr.Gawad
 
Membranous Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
Membranous Nephropathy (KDIGO 2021 Guidelines) - Dr. GawadMembranous Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
Membranous Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
NephroTube - Dr.Gawad
 
Infection-related Glomerulonephritis (KDIGO 2021 Guidelines) - Dr. Gawad
Infection-related Glomerulonephritis  (KDIGO 2021 Guidelines) - Dr. GawadInfection-related Glomerulonephritis  (KDIGO 2021 Guidelines) - Dr. Gawad
Infection-related Glomerulonephritis (KDIGO 2021 Guidelines) - Dr. Gawad
NephroTube - Dr.Gawad
 
Ig & complement-mediated glomerular dis with MPGN pattern (KDIGO 2021) - Dr.G...
Ig & complement-mediated glomerular dis with MPGN pattern (KDIGO 2021) - Dr.G...Ig & complement-mediated glomerular dis with MPGN pattern (KDIGO 2021) - Dr.G...
Ig & complement-mediated glomerular dis with MPGN pattern (KDIGO 2021) - Dr.G...
NephroTube - Dr.Gawad
 
IgA Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
IgA Nephropathy (KDIGO 2021 Guidelines) - Dr. GawadIgA Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
IgA Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
NephroTube - Dr.Gawad
 
Adult Minimal Change Disease (KDIGO 2021 Guidelines)
Adult Minimal Change Disease (KDIGO 2021 Guidelines)Adult Minimal Change Disease (KDIGO 2021 Guidelines)
Adult Minimal Change Disease (KDIGO 2021 Guidelines)
NephroTube - Dr.Gawad
 
Insights from the FIGARO-DKD and FIDELIO-DKD trials - Dr. Gawad
Insights from the FIGARO-DKD and FIDELIO-DKD trials - Dr. GawadInsights from the FIGARO-DKD and FIDELIO-DKD trials - Dr. Gawad
Insights from the FIGARO-DKD and FIDELIO-DKD trials - Dr. Gawad
NephroTube - Dr.Gawad
 
Diabetes Mellitus Management in CKD (Clinical Tips) - Dr. Gawad
Diabetes Mellitus Management in CKD (Clinical Tips) - Dr. GawadDiabetes Mellitus Management in CKD (Clinical Tips) - Dr. Gawad
Diabetes Mellitus Management in CKD (Clinical Tips) - Dr. Gawad
NephroTube - Dr.Gawad
 
Hypokalemia (Practical Approach) - Dr. Gawad
Hypokalemia (Practical Approach) - Dr. GawadHypokalemia (Practical Approach) - Dr. Gawad
Hypokalemia (Practical Approach) - Dr. Gawad
NephroTube - Dr.Gawad
 

More from NephroTube - Dr.Gawad (20)

Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.GawadHemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
 
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.GawadHemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
 
Vitamin D in Chronic Kidney Disease Which type, Which dose, Which patient? - ...
Vitamin D in Chronic Kidney Disease Which type, Which dose, Which patient? - ...Vitamin D in Chronic Kidney Disease Which type, Which dose, Which patient? - ...
Vitamin D in Chronic Kidney Disease Which type, Which dose, Which patient? - ...
 
Urinary Tract Infection (Clinical Tips) - Dr. Gawad
Urinary Tract Infection (Clinical Tips) - Dr. GawadUrinary Tract Infection (Clinical Tips) - Dr. Gawad
Urinary Tract Infection (Clinical Tips) - Dr. Gawad
 
Contrast and the kidney - Dr. Gawad
Contrast and the kidney - Dr. GawadContrast and the kidney - Dr. Gawad
Contrast and the kidney - Dr. Gawad
 
Obesity and the Kidney (Link and Evidence) - Dr. Gawad
Obesity and the Kidney (Link and Evidence) - Dr. GawadObesity and the Kidney (Link and Evidence) - Dr. Gawad
Obesity and the Kidney (Link and Evidence) - Dr. Gawad
 
Thrombotic Microangiopathy (TMA) in Adults and Acute Kidney Injury - Dr. Gawad
Thrombotic Microangiopathy (TMA) in Adults and Acute Kidney Injury - Dr. GawadThrombotic Microangiopathy (TMA) in Adults and Acute Kidney Injury - Dr. Gawad
Thrombotic Microangiopathy (TMA) in Adults and Acute Kidney Injury - Dr. Gawad
 
Asymptomatic Hyperuricemia with CKD (To Treat or Not To Treat) - Dr. Gawad
Asymptomatic Hyperuricemia with CKD (To Treat or Not To Treat) - Dr. GawadAsymptomatic Hyperuricemia with CKD (To Treat or Not To Treat) - Dr. Gawad
Asymptomatic Hyperuricemia with CKD (To Treat or Not To Treat) - Dr. Gawad
 
ANCA vasculitis (KDIGO 2021 Guidelines) - Dr. Gawad
ANCA vasculitis (KDIGO 2021 Guidelines) - Dr. GawadANCA vasculitis (KDIGO 2021 Guidelines) - Dr. Gawad
ANCA vasculitis (KDIGO 2021 Guidelines) - Dr. Gawad
 
Lupus Nephritis (KDIGO 2021 Guidelines) - Dr. Gawad
Lupus Nephritis (KDIGO 2021 Guidelines) - Dr. GawadLupus Nephritis (KDIGO 2021 Guidelines) - Dr. Gawad
Lupus Nephritis (KDIGO 2021 Guidelines) - Dr. Gawad
 
Membranous Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
Membranous Nephropathy (KDIGO 2021 Guidelines) - Dr. GawadMembranous Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
Membranous Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
 
Infection-related Glomerulonephritis (KDIGO 2021 Guidelines) - Dr. Gawad
Infection-related Glomerulonephritis  (KDIGO 2021 Guidelines) - Dr. GawadInfection-related Glomerulonephritis  (KDIGO 2021 Guidelines) - Dr. Gawad
Infection-related Glomerulonephritis (KDIGO 2021 Guidelines) - Dr. Gawad
 
Ig & complement-mediated glomerular dis with MPGN pattern (KDIGO 2021) - Dr.G...
Ig & complement-mediated glomerular dis with MPGN pattern (KDIGO 2021) - Dr.G...Ig & complement-mediated glomerular dis with MPGN pattern (KDIGO 2021) - Dr.G...
Ig & complement-mediated glomerular dis with MPGN pattern (KDIGO 2021) - Dr.G...
 
IgA Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
IgA Nephropathy (KDIGO 2021 Guidelines) - Dr. GawadIgA Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
IgA Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
 
Adult Minimal Change Disease (KDIGO 2021 Guidelines)
Adult Minimal Change Disease (KDIGO 2021 Guidelines)Adult Minimal Change Disease (KDIGO 2021 Guidelines)
Adult Minimal Change Disease (KDIGO 2021 Guidelines)
 
Insights from the FIGARO-DKD and FIDELIO-DKD trials - Dr. Gawad
Insights from the FIGARO-DKD and FIDELIO-DKD trials - Dr. GawadInsights from the FIGARO-DKD and FIDELIO-DKD trials - Dr. Gawad
Insights from the FIGARO-DKD and FIDELIO-DKD trials - Dr. Gawad
 
Diabetes Mellitus Management in CKD (Clinical Tips) - Dr. Gawad
Diabetes Mellitus Management in CKD (Clinical Tips) - Dr. GawadDiabetes Mellitus Management in CKD (Clinical Tips) - Dr. Gawad
Diabetes Mellitus Management in CKD (Clinical Tips) - Dr. Gawad
 
Hypokalemia (Practical Approach) - Dr. Gawad
Hypokalemia (Practical Approach) - Dr. GawadHypokalemia (Practical Approach) - Dr. Gawad
Hypokalemia (Practical Approach) - Dr. Gawad
 

Recently uploaded

Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
chandankumarsmartiso
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
planning for change nursing Management ppt
planning for change nursing Management pptplanning for change nursing Management ppt
planning for change nursing Management ppt
Thangamjayarani
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 

Recently uploaded (20)

Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
planning for change nursing Management ppt
planning for change nursing Management pptplanning for change nursing Management ppt
planning for change nursing Management ppt
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 

Dysproteinemias Related Renal Disorders, Monoclonal Gammopathy (Paraproteinemia), Nephrology Perspective - Dr. Gawad

  • 1. Dysproteinemias Related Renal Disorders Monoclonal Gammopathy (Paraproteinemia) Nephrology Perspective Mohammed Abdel Gawad Lecturer of Nephrology, School of Medicine, NewGiza University Nephrology Consultant, Alexandria MD Nephrology, Mansoura University European Specialty Examination in Nephrology (ESENeph) – UK Founder of NephroTube.com Annual Conference of Assiut – Nephrology Chapter – 28 October 2021
  • 2. To download the lecture contact me drgawad@gmail.com For more Nephrology lectures visit www.NephroTube.com
  • 3.
  • 4. Talk Outline • Back to basics • Kidney deposits: Hypothesized mechanism / Clinical presentation • Dysproteinemia diagnosis: Lab • Dysproteinemia diagnosis: Renal biopsy • Dysproteinemia diagnosis: Bone marrow biopsy • Monoclonal Gammopathy of Renal Significance (MGRS) • High cutoff dialyzers • Final message
  • 5. Talk Outline • Back to basics • Kidney deposits: Hypothesized mechanism / Clinical presentation • Dysproteinemia diagnosis: Lab • Dysproteinemia diagnosis: Renal biopsy • Dysproteinemia diagnosis: Bone marrow biopsy • Monoclonal Gammopathy of Renal Significance (MGRS) • High cutoff dialyzers • Final message
  • 6. Monoclonal Abs (Ig, Gama Globulin) • Antibodies that are identical because they were produced by one type of B cell. • Detect only one epitope on the antigen. • Antibodies that are non-identical because they were produced by different B cell resources. • Detect multiple epitopes on any one antigen. Polyclonal Abs (Ig, Gama Globulin) Semin Immunol. 2008;20:49
  • 7. Monoclonal gammopathy (paraproteinemia) signifies the production of monoclonal immunoglobulin or immunoglobulin fragments (i.e., light or heavy chains) by a clonal proliferation of plasma cells or B cells Am J Kidney Dis (2019), 74(6):822-836
  • 8. Talk Outline • Back to basics • Kidney deposits: Hypothesized mechanism / Clinical presentation • Dysproteinemia diagnosis: Lab • Dysproteinemia diagnosis: Renal biopsy • Dysproteinemia diagnosis: Bone marrow biopsy • Monoclonal Gammopathy of Renal Significance (MGRS) • High cutoff dialyzers • Final message
  • 9. Monoclonal gammopathy - associated renal lesions Kidney International (2015) 87, 698–711
  • 11. Dysproteinemia-Associated Kidney Diseases: Hypothesized mechanism of injury Am J Kidney Dis (2019), 74(6):822-836
  • 12. Dysproteinemia-Associated Kidney Diseases: Hypothesized mechanism of injury Am J Kidney Dis (2019), 74(6):822-836
  • 13. Talk Outline • Back to basics • Kidney deposits: Hypothesized mechanism / Clinical presentation • Dysproteinemia diagnosis: Lab • Dysproteinemia diagnosis: Renal biopsy • Dysproteinemia diagnosis: Bone marrow biopsy • Monoclonal Gammopathy of Renal Significance (MGRS) • High cutoff dialyzers • Final message
  • 14. Serum protein electrophoresis (SPE) Paraprotein is a monoclonal Ig (gamma globulin) that is produced in excess by the clonal proliferation of plasma cells Electrophoresis. 1997;18:1775-1780
  • 15. Serum protein electrophoresis (SPE) Serum immunofixation electrophoresis (sIFE) Can detect the whole immunoglobulin (cannot reliably differentiate monoclonal from polyclonal light chain expansion) 10 times more sensitive for immunoglobulins Only detects increased LC in patients who have very high levels of LC-only myeloma 10 times more sensitive for LC Semi-quantitative Not quantitative Laboratory Diagnostic Tests Clin Chem. 2002;48(9):1437-1444
  • 16. Urine PEP, immunofixation electrophoresis (uIFS) (to detect Bence Jones Proteinuria) Serum PEP, immunofixation electrophoresis (sIFE) • Can detect low levels of LC • Yet remains less sensitive than sFLC measurement because sFLC are elevated before urine overflow may occur. More sensitive Dr. Henry Bence-Jones 31 December 1813 / / April 20, 1873 Laboratory Diagnostic Tests
  • 17. Serum Free Light Chains (к and λ) Measurement Normal к/λ CKD к/λ Abnormal к/λ ratio 0.26–1.65 0.37–3.17 Significant accumulation of sFLC occurs (approximately five-fold) Occurs as a result of overproduction of a single к or λ clone Am J Kidney Dis (2019), 74(6):822-836
  • 18. Am J Kidney Dis (2019), 74(6):822-836
  • 19. Dysproteinemia-Associated Kidney Diseases: Paraprotein detection rate Am J Kidney Dis (2019), 74(6):822-836
  • 20. Diagnosis of dysproteinemia Urine Analysis Discrepancy between PCR in urine and dipstick results suggests LC deposition disease Light chain proteins are not detected by dipstick but are counted through PCR Light chain proteins are counted through PCR but will not affect ACR Discrepancy between PCR and ACR in urine suggests LC deposition disease
  • 21. Talk Outline • Back to basics • Kidney deposits: Hypothesized mechanism / Clinical presentation • Dysproteinemia diagnosis: Lab • Dysproteinemia diagnosis: Renal biopsy • Dysproteinemia diagnosis: Bone marrow biopsy • Monoclonal Gammopathy of Renal Significance (MGRS) • High cutoff dialyzers • Final message
  • 22. Comprehensive Clinical Nephrology. 4th edition, chapter 26
  • 23. J Am Soc Nephrol 19: 34–37, 2008
  • 24. J Am Soc Nephrol 19: 34–37, 2008
  • 25. J Am Soc Nephrol 19: 34–37, 2008 DNAJB9 is novel proteomic tissue biomarker specific for fibrillary glomerulonephritis on immunohistochemistry Kidney Int Rep. 2017 Aug 8;3(1):56-64
  • 26. Immunotactoid glomerulopathy Am J Kidney Dis (2019), 74(6):822-836
  • 27. κ light chain monoclonal immunoglobulin deposition disease Am J Kidney Dis (2019), 74(6):822-836
  • 28. Proliferative glomerulonephritis with monoclonal immunoglobulin G3 (IgG3) κ deposits Am J Kidney Dis (2019), 74(6):822-836
  • 29. Am J Kidney Dis (2019), 74(6):822-836 Light chain cast nephropathy
  • 30. Talk Outline • Back to basics • Kidney deposits: Hypothesized mechanism / Clinical presentation • Dysproteinemia diagnosis: Lab • Dysproteinemia diagnosis: Renal biopsy • Dysproteinemia diagnosis: Bone marrow biopsy • Monoclonal Gammopathy of Renal Significance (MGRS) • High cutoff dialyzers • Final message
  • 31. Kidney International (2011) 79, 1289–1301 Dysproteinemia-Associated Kidney Diseases: Clone detection
  • 32. Am J Kidney Dis (2019), 74(6):822-836 Dysproteinemia-Associated Kidney Diseases: Clone detection
  • 33. Talk Outline • Back to basics • Kidney deposits: Hypothesized mechanism / Clinical presentation • Dysproteinemia diagnosis: Lab • Dysproteinemia diagnosis: Renal biopsy • Dysproteinemia diagnosis: Bone marrow biopsy • Monoclonal Gammopathy of Renal Significance (MGRS) • High cutoff dialyzers • Final message
  • 34. MGUS MGRS Smoldering (asymptomatic) myeloma Active (symptomatic) myeloma Serum M-protein <3 g/100ml <3 g/100ml 3 g/100ml 3 g/100ml Bone marrow clonal plasma cells <10% <10% 10% 10% or Plasmacytoma Related organ or tissue impairment Absent and No evidence of other B-cell proliferative disorders Renal injury Absent/ Asymptomatic Requires 1 or more of the following: • Calcium elevation • Renal insufficiency • Anaemia • Bone osteolytic lesion Monoclonal Gammopathy of Renal Significance (MGRS) Am J Kidney Dis (2019), 74(6):822-836
  • 35. Talk Outline • Back to basics • Kidney deposits: Hypothesized mechanism / Clinical presentation • Dysproteinemia diagnosis: Lab • Dysproteinemia diagnosis: Renal biopsy • Dysproteinemia diagnosis: Bone marrow biopsy • Monoclonal Gammopathy of Renal Significance (MGRS) • High cutoff dialyzers • Final message
  • 38. 90 patients Lancet Haematol. 2019 Apr;6(4):e217-e228
  • 39. Talk Outline • Back to basics • Kidney deposits: Hypothesized mechanism / Clinical presentation • Dysproteinemia diagnosis: Lab • Dysproteinemia diagnosis: Renal biopsy • Dysproteinemia diagnosis: Bone marrow biopsy • Monoclonal Gammopathy of Renal Significance (MGRS) • High cutoff dialyzers • Final message
  • 40. Suspected dysproteinemia in a kidney disease SPEP, Serum immunofixation, SFLC +ve for dysproteinemia Bone marrow biopsy Target treatment for the type of clonal proliferation -ve for dysproteinemia High suspicion for dysproteinemia in a kidney disease Renal biopsy +ve for dysproteinemia -ve for dysproteinemia Follow up and treatment according to presentation